ETFS S&P Biotech is under Algo Engine buy conditions and was added to our “high conviction” model following the low formed at $52.
The ETF has since rallied 20% and the buying momentum among biotech stocks remains strong.

ETFS S&P Biotech is under Algo Engine buy conditions and was added to our “high conviction” model following the low formed at $52.
The ETF has since rallied 20% and the buying momentum among biotech stocks remains strong.
